Angiotensin-(1-7) Provides Potent Long-Term Neurorepair/Neuroregeneration in a Rodent White Matter Stroke Model: Nonarteritic Ischemic Optic Neuropathy (rNAION)
Cells · 2025
DOI: 10.3390/cells14040289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Kwang Min Woo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medical School, New York, NY 10021, USA. Hauptthemen laut MEDLINE: Optic Neuropathy, Ischemic, Angiotensin I, Peptide Fragments, White Matter. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, Constant Therapeutics LLC.
Themen: Schlaganfall
Abstract (Originalsprache)
Nonarteritic anterior ischemic optic neuropathy (NAION) is an ischemic lesion of the anterior optic nerve (ON), currently untreatable due to the length of time from symptom onset until treatment. We evaluated angiotensin-(1-7) (Ang-(1-7)): the MAS1-receptor ligand, as a possible NAION treatment using the rodent NAION model (rNAION). Long-Evans rats were unilaterally rNAION-induced. One-day post-induction, lesion severity was quantified via optic nerve head (ONH) edema using spectral domain optical coherence tomography. Animals meeting rNAION induction criteria were randomized into (1) Subcutaneous Ang-(1-7) infusion for 28 days and (2) Vehicle. Visual function was assessed using both visual acuity and flash visual evoked potentials (fVEP). Tissues were collected >30d and RGC neurons were quantified by stereology. ONs were histologically examined for inflammation. Ang-(1-7) improved post-rNAION visual function. Ang-(1-7)-treated animals showed improved visual acuity (ANCOVA: p = 0.0084) and improved fVEP amplitudes (ANCOVA: p = 0.0378) vs vehicle controls. The relative degree of improvement correlated with ONH edema severity. Treated animals showed trends towards increased RGC survival, and reduced optic nerve inflammatory cell infiltration. Ang-(1-7) is the first agent effective ≥1 day after rNAION induction. Ang-(1-7) type agonists may be useful in improving long-term function and neuronal survival in clinical NAION and other forms of white matter ischemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Weill Cornell Medical School, New York, NY 10021, USA.
- Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Constant Therapeutics, LLC, Boston, MA 02210, USA.
- Medical School Berlin, Berlin 14197, Germany.
- Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
ORCID-Profile: Steven L Bernstein
Förderung
- NEI NIH HHS
- NIH HHS
- Constant Therapeutics LLC
- Hillside Foundation
- NIH
Zitieren
APA
Woo, K. M., Guo, Y., Mehrabian, Z., Walther, T., Miller, N. R., & Bernstein, S. L. (2025). Angiotensin-(1-7) Provides Potent Long-Term Neurorepair/Neuroregeneration in a Rodent White Matter Stroke Model: Nonarteritic Ischemic Optic Neuropathy (rNAION). Cells. https://doi.org/10.3390/cells14040289
Vancouver
Woo KM, Guo Y, Mehrabian Z, Walther T, Miller NR, Bernstein SL. Angiotensin-(1-7) Provides Potent Long-Term Neurorepair/Neuroregeneration in a Rodent White Matter Stroke Model: Nonarteritic Ischemic Optic Neuropathy (rNAION). Cells. 2025. doi:10.3390/cells14040289
BibTeX
@article{Woo2025,
author = {Woo, Kwang Min and Guo, Yan and Mehrabian, Zara and Walther, Thomas and Miller, Neil R and Bernstein, Steven L},
title = {Angiotensin-(1-7) Provides Potent Long-Term Neurorepair/Neuroregeneration in a Rodent White Matter Stroke Model: Nonarteritic Ischemic Optic Neuropathy (rNAION)},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14040289}
}
EUVIMED